As of 2025-06-29, the Relative Valuation of Pharmaxis Ltd (PXS.AX) is (0.21) AUD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 AUD, the upside of Pharmaxis Ltd based on Relative Valuation is -1039.7%.
The range of the Relative Valuation is (0.19) - (0.21) AUD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 13.5x | 12.5x |
| Forward P/E multiples | 11.9x - 23.6x | 13.8x |
| Fair Price | (0.19) - (0.21) | (0.21) |
| Upside | -951.8% - -1064.7% | -1039.7% |
| Date | P/E |